ERYTHROMYCIN ETHYLSUCCINATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for erythromycin ethylsuccinate and what is the scope of freedom to operate?

Erythromycin ethylsuccinate is the generic ingredient in twelve branded drugs marketed by Azurity, Amneal Pharms, Ani Pharms, Cadila Pharms Ltd, Endo Operations, Ross Labs, Pharmacia And Upjohn, Arbor Pharms Llc, Alpharma Us Pharms, Dista, Naska, Parke Davis, Pharmafair, Wyeth Ayerst, Aurobindo Pharma Usa, Barr, and Alra, and is included in twenty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for erythromycin ethylsuccinate. Eight suppliers are listed for this compound.

Sponsor	Phase
University of Florida	Phase 2
Metabolic Solutions Inc.	Phase 2

Sponsor

Phase

University of Florida

Phase 2

Metabolic Solutions Inc.

Phase 2

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aurobindo Pharma Usa	ERYTHROMYCIN ETHYLSUCCINATE	erythromycin ethylsuccinate	TABLET;ORAL	062847-001	Sep 14, 1988		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Parke Davis	ERYTHROMYCIN ETHYLSUCCINATE	erythromycin ethylsuccinate	SUSPENSION;ORAL	062231-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alra	ERYZOLE	erythromycin ethylsuccinate; sulfisoxazole acetyl	GRANULE;ORAL	062758-001	Jun 15, 1988		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ross Labs	PEDIAMYCIN	erythromycin ethylsuccinate	GRANULE;ORAL	062305-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ross Labs	PEDIAMYCIN	erythromycin ethylsuccinate	SUSPENSION/DROPS;ORAL	062305-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ani Pharms	ERYTHROMYCIN ETHYLSUCCINATE	erythromycin ethylsuccinate	GRANULE;ORAL	062055-003	Nov 2, 2018	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

US Patents:	0
Tradenames:	12
Applicants:	17
NDAs:	25
Drug Master File Entries:	14
Finished Product Suppliers / Packagers:	8
Raw Ingredient (Bulk) Api Vendors:	48
Clinical Trials:	1
Patent Applications:	8,715
What excipients (inactive ingredients) are in ERYTHROMYCIN ETHYLSUCCINATE?	ERYTHROMYCIN ETHYLSUCCINATE excipients list
DailyMed Link:	ERYTHROMYCIN ETHYLSUCCINATE at DailyMed

Drug Class	Macrolide Antimicrobial Macrolide
Physiological Effect	Decreased Sebaceous Gland Activity